search icon
  • Print
  • ShareThis
  • Text Size
  •  

    2017 Board of Directors Candidates 

    The bios for the candidates for the 2017 Board of Directors elections are listed below for both IDSA and HIVMA.

     

    IDSA Board of Directors 2017 Candidates

  • IDSA Vice President - Thomas M. File, Jr., MD, MSc, FIDSA

     

    Education:   Albion College, AB, cum laude;  University of Michigan School of Medicine, MD, 1972; Intern and Resident in Internal Medicine, Riverside Methodist Hospital, Columbus, OH, 1972-1975; Fellow in Infectious Diseases, Ohio State University, 1975-1977; Ohio State University, MSc, Medical Microbiology, 1977

    Current Appointments:   Chair Infectious Disease Division, Summa Health, Akron, Ohio; Professor of Medicine, Master Teacher, Chair Infectious Disease Section, Northeast Ohio Medical University.

    IDSA Participation:  Infectious Diseases Society of America, IDSA (Fellow); Board of Directors, 2008-2011; Clinical Practice Guidelines Committee, 2002-2008, Chairperson, 2005-2008; Past President, Infectious Diseases Society of Ohio; Recipient of the Watanakunakorn Clinician Award, 2012; Community-Acquired Pneumonia Guideline Panel, 1996-2007; Influenza Guideline panel, 2008-present; Hospital-Associated Pneumonia Guideline panel, 2013-present; Sinusitis Guideline panel, 2008; IDSA Awards Committee, 2014-2016; IDSA/National Foundation for Infectious Diseases (NFID) Joint Research Awards Committee, 2007-2015; Member, HIV Medicine Association; IDSA representative: The Joint Commission and the American Medical Association-Physician Consortium for Performance Improvements; National Summit of Overuse - "Antibiotics for Viral Infections" section, 2012; National Quality Forum-Infectious Diseases Project  Steering Committee, 2012; Agency for Healthcare Research and Quality (AHRQ) ,Key Informant for panel on, "Reducing Inappropriate Antibiotic Use for Acute Respiratory Tract Infections, " 2013-14; Member, Clinical Subcommittee of Pulmonary Diseases, Medicare Access and Chip Reauthorization Act (MACRA) Episode-Based Resource Use Measures project, 2017.

    Research Interests:   Randomized clinical trials for safety and efficacy of new antimicrobials;

    Community-acquired pneumonia; Impact of new diagnostics and antimicrobial stewardship on

    Patient outcomes.

    Other:   Editor-in-Chief, Infectious Diseases in Clinical Practice; National Foundation for Infectious Diseases: Past President,  Board of Directors, 2004-2016, President, 2012-2014, Chairperson CME committee, 2006-2008; Recipient of the John Utz Leadership Award, 2017; American College of Physicians :Fellow, 1981, Master, 2007; ACP Ohio Chapter Master Teaching award , 2004; NEOMED: Master Teacher designation, 2001,Outstanding Clinical Research Award, 2010; Foundation for the National Institutes of Health Biomakers consortium HABP/VABP project team for: Considerations for clinical trial design for the study of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia, 2014-2017; Making a Difference in Infectious Diseases (MAD-ID) ,Scientific Committee; Society membership: American Society of  Microbiology; American College of Chest Physicians, Fellow; American Thoracic Society; European Society of Clinical Microbiology and Infectious Diseases; Northeastern Ohio Task Force on AIDS (founding member and past President)                           

    Personal Statement:   Since fellowship, my primary focus has been the clinical practice of infectious diseases at a community teaching hospital.  I recognize the importance for the society to support the practicing clinician as well as those in academic or industry positions.  It is vital to the Society's future that we continue to emphasize the value of our discipline, improve reimbursement, and advocate for significant roles such as antimicrobial stewardship and infection epidemiology. Despite what was considered many years ago that it was time to close the books on infectious diseases, the burden of infectious diseases today is more significant than ever (particularly the impact of emerging infections and antimicrobial resistance); thus the core purposes of IDSA (to promote excellence in patient care, education, research, public health and prevention relating to infectious diseases; and to serve the needs of the members) will continue to be highly important.

    With the many anticipated changes in healthcare, there will be many challenges ahead.  There will also be opportunities to expand the success of the society.  I support the 'steps toward a reinvigorated interest in the specialty of infectious disease' as listed in Walensky, et al (Clin Infect dis. 2017; 64: 1299) which includes: alternative careers, co-certification, novel programs with NIH, and reform of reimbursement structure for cognitive specialties. I also support the need to emphasize evidence-based approaches to diagnosis and management of ID based on our guidelines and advocacy in government.  I look forward to the opportunity to contribute to the success of our society.

     

    IDSA Vice President - Steven K. Schmitt, MD, FIDSA

     

    Education:  Haverford College, 1982; University of Cincinnati College of Medicine, 1988; Internal Medicine Resident, Cleveland Clinic, 1988-91; Infectious Diseases Fellow, Cleveland Clinic,

    1991-94.

    Current appointments:  Head, Section of Bone and Joint Infections, Department of Infectious Disease, Cleveland Clinic; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Associate Hospital Epidemiologist, Cleveland Clinic.

    IDSA participation:  IDSA Board of Directors, 2013-2016; President, Infectious Diseases Society of Ohio, 2002-4; Board of State and Regional Societies 2004-7; Quality Improvement Task Force 2008-11; Clinical Affairs Committee 2008-2013 (chair 2011-2013); Chair, Value of Infectious Diseases Specialists Task Force, 2009-2013; IDSA advisor to American Medical Association CPT Advisory Committee, 2008-present; IDSA advisor to American Medical Association Relative Value Update (RUC) Advisory Committee, 2012-2015; Vertebral Osteomyelitis Guideline Panel, 2010-2015; Emerging Infections Network; IDSA Truven Value Project, 2016-present; Centers for Medicare and Medicaid Services (CMS) Medicare and CHIP Reauthorization Act (MACRA) Musculoskeletal Episode Grouper Subcommittee, 2017-present.

    Research interests: musculoskeletal infections, value of infectious diseases physicians.

    Other:  President, Musculoskeletal Infection Society, 2015-2016; Director's Committee on Emerging and Healthcare - Associated Infections, Ohio Department of Health, 2000-present; Hospital Measures Advisory Council Infection Control Group, Ohio Department of Health, 2007-2016; Executive Board, Musculoskeletal Infection Society, 2012-present; Vice Chair for Professional Staff Affairs, Medicine Institute, Cleveland Clinic, 2010-2015; Council for Professional Staff Development/Professionalism Council, Cleveland Clinic, 2012-present; Professional Staff Experience and Support Committee, Cleveland Clinic, 2016-present; FIDSA, 2006; FACP, 2010.

    Personal statement: Change remains the only constant, but even Heraclitus could not have anticipated the pace of change affecting ID physicians.  In all domains, we are asked to do more with less and with transparency.  Electronic records and communications have redefined the core healthcare interaction.  Policy uncertainty clouds the implementation of value based care and the viability of strategic programs.  New and resistant pathogens dramatically affect people and societies.  We have reached new heights of scientific ability, but are challenged to resource it in a way that serves careers, institutions, and patients.  Trainees scrutinize what specialties offer.  Healthcare systems ask why we should lead and other specialists are moving to assert leadership in spaces inherent to ID. 

    Fortunately, ID specialists self-select with skills that allow us a disproportionately large footprint in healthcare.  We are consummate physicians, systems thinkers, and team builders.  We are fiercely curious investigators and collegial problem solvers.  We have proven value in large clinical datasets, prevention, and stewardship.

    Looking forward, the challenge for IDSA is to help members seize the opportunity of change.  We must prove, then articulate with metrics of our choosing, our value in clinical and academic domains, earning financial and career recognition.  We must inform new approaches linking the bench and bedside.  We must harness distance health to spread our footprint.  We must build our brand and member resources as the preeminent experts in the art and science of ID, epidemiology, stewardship, and public health.  We must innovate through effective teams with kindred organizations, industry, and government.   We must develop leaders and influence with assertive outreach.  Finally, we must ensure a rich experience inside and outside medicine for all members.  If we can achieve these goals and show passion for the path, then the best trainees will fear missing out on a career in ID.  It is a privilege to serve IDSA as we seek this future.

     


     

    Director #1 - Archana Chatterjee, MD, PhD, FIDSA

     

    Education:  Army Public School, Delhi, India, National Scholar, 1979 ; Armed Forces Medical College, Pune, India, National Scholar, 1983 ; University of Nebraska Medical Center (UNMC), Presidential Fellow, 1993 ; House Officer, Department of Pediatrics, UNMC/Creighton University, 1993-1995; Assistant Instructor (Sub-specialty Fellowship), Division of Pediatric Infectious Diseases, Creighton University, 1996-1998.

    Current Appointments:  Professor and Chair of the Department of Pediatrics and Senior Associate Dean for Faculty Development at the University of South Dakota (USD) Sanford School of Medicine; Professor, Master's in Public Health, USD/South Dakota State University; Clinical Investigator, Sanford Research.

    IDSA Participation: Fellow of IDSA, 2005; Member, Publication Committee, 2006-2009; Liaison member, Standards and Practice Guidelines Committee, 2011-Present; Member, Task Force on Practice Guidelines, 2016; Vice-chair Bone and Joint Infections Guideline Committee for Pediatric Infectious Diseases Society (PIDS)/IDSA, 2012-Present; Member, Vice-Chair and Chair, Program Committee IDWeek (representing PIDS), 2015, 2016 and 2017, respectively.

    Research Interests: Primary field of work is in vaccines - conducted over 50 clinical trials as PI, lectured nationally and internationally on the subject, and published over 30 peer-reviewed articles and a book on the topic.  Other research interests include clinical trials of new antimicrobials,  hospital epidemiology, community-acquired methicillin-resistant Staphylococcus aureus, inhibition of Helicobacter pylori by nutraceuticals, and antibiotic resistance. 

    Other: Board certified in Pediatric Infectious Diseases since 2001;  Advisory Committee Service Award:  "In recognition of distinguished service to the people of the United States of America, presented by the US Food and Drug Administration Anti-Infective Drugs Advisory Committee," 2012; Board of Directors, Association of Medical School Pediatric Department Chairs (AMSPDC), 2017; AMSPDC liaison to the Association of American Medical Colleges (AAMC), 2017; AAMC Council of Deans Fellow (1/5 in the country), 2016-2017; Chair Elect, AAMC Group on Women in Medicine and Science ,2016; Member, AAMC Distinguished Research Award Selection Committee, 2016-Present; Steering Committee, AAMC Group on Faculty Affairs, 2010-2013; Member, Membership and Research Committees, AMSPDC, 2015-Present; Member, PIDS Nominations and Awards Committee 2014-Present, Program and Meetings Committee, 2010-Present, Clinical Affairs Committee, 2010-Present; Member, Education Committee, Society for Healthcare Epidemiology of America (SHEA), 2008-2012.

    Personal Statement: IDSA is the premier organization that provides its members with a critical forum to effectively contribute their clinical, educational, research, advocacy skills and expertise in the US and around the world.  Having served on its committees over several years, particularly the Program Committee for IDWeek, I am keenly aware of its focus on advancing the field of infectious diseases through scientifically credible initiatives. IDSA has been and needs to remain a respected authority that brings to bear its considerable influence on all matters relating to infectious diseases.  It must continue to strengthen its partnerships with sister organizations such as PIDS, SHEA and HIVMA, and expand its sphere of influence to include governmental, policy-making, educational, community, non-profit and other professional organizations. With my experiences and expertise gained through the professional leadership roles I have fulfilled, as well as the time and effort I have volunteered to serve various organizations, I believe I will bring a unique skill set to the IDSA Board of Directors. I envision a bright future for the IDSA and would be deeply honored to be part of its distinguished leadership.


     

    Director #1 - Tina Q. Tan, MD, FIDSA

     

    Education: University of New Orleans,  BS Biology, 1982; Louisiana State University School of Medicine, 1988; Pediatric Intern and Resident, Baylor College of Medicine, 1988-1991; Chief Resident, Baylor College of Medicine, 1990-1991; Pediatric Infectious Diseases Fellowship, Baylor College of Medicine, 1991-1994.

    Current Appointments: Professor of Pediatrics, Feinberg School of Medicine, Northwestern University; Medical Director - International Patient Services Program, Infectious Diseases Attending, Medical Director - International Adoptee Clinic, Medical Co-Director - Travel Medicine Clinic, Ann & Robert H. Lurie Children's Hospital of Chicago.

    IDSA Participation: Antibiotic Use and Clinical Trials Committee, 2001-2004; PIDS Liaison to IDSA Program and Meetings Committee, 2009 - 2014; IDWeek Vice Chairperson, PIDS - IDSA Program and Meetings Committee, 2012-2013; IDWeek Chairperson, PIDS - IDSA Program and Meetings committee, 2014; IDSA Training Fellow Mentor, IDWeek 2015 - present; Session organizer of the Pediatric Hot Topics session and moderator of multiple IDSA sessions, 2009-present.

    Research Interests: Pertussis disease and vaccine, pneumococcal disease epidemiology and vaccine, CA-MRSA infections, antibiotic resistance, vaccines and vaccine preventable diseases, general infectious diseases, and vaccine education for healthcare providers.

    Other: Member, Immunization Advisory Committee for the State of Illinois Department of Public Health, 1996-present; Clinical Practice Director, Division of Infectious Diseases, Ann & Robert H. Lurie Children's Hospital of Chicago, 1999-2012; American Academy of Pediatrics (AAP): PREP: the course (Pediatrics Board Review Course), Planning Group Member, 2006-2012; PREP ID: 2007 (Pediatric ID Board Review Course), PIDS representative to planning committee 2006-2011; Co-Course Director, PREP ID: 2009, 2011- PIDS representative; Member, Executive Committee of the AAP Section on Infectious Diseases, 2009-present; Section on Infectious Diseases, Education Subcommittee, 2005-2014; Chairperson, 2010-2014; Chairperson, AAP Section on Infectious Diseases (SOID), 2014-present; Member, AAP Committee on Infectious Diseases (COID Redbook Committee), 2014- present; Member, Antimicrobial Resistance and Stewardship Workgroup of AAP COID - Education Subcommittee, 2015- present; Member, Emerging Infections and Outbreak Committee of AAP COID, 2015-present; Member, AAP Global Immunization Advocacy Project Advisory Committee (GIA-PAC), 2011- present; Technical Advisor, AAP-CDC Global Immunization Advocacy Project, 2016-present; Member, ACIP of Centers for Disease Control and Prevention (CDC) Pertussis Working Group (COID representative); Pediatric Infectious Disease Society (PIDS):  Communications Committee and Clinical Affairs Committee, 2000-2002; Public Policy Committee, 2003 - 2006; Programs and Meeting Committee, 2005-present, co-chairperson, 2011-2015; Awards and Nominations Committee, 2006-2015; Governing Council Member, 2008 - 2012; Board of Trustees Member, Education and Research Foundation, 2008-2012; Steering Committee Member, Global Pertussis Initiative, 2003 to present; Member of the Board of Directors, World Association of Infectious Diseases and Immunological Diseases (WAidid), 2015-present; Member, American Board of Pediatrics Global Health Task Force - Dissemination and Advocacy Work Group, 2016-present; Member, Advisory Commission on Childhood Vaccine - U.S. Health Resources and Services Administration, 2016-present.

    Personal Statement: A quote from the William Cowper poem "The Task" states that "Diversity makes lift interesting…variety is the spice of life." The same could be said for the field of Infectious Diseases for which there is quite a diversity of career opportunities and this diversity continues to grow as the responsibilities of the ID physician continue to rapidly expand into new areas of research and clinical practice. The contributions of ID physicians are vital to all the different fields of medicine in improving patient outcomes. Strengthening partnerships with our sister societies (PIDS, SHEA, HIVMA) allows us to work together to rapidly address issues that affect all or a select population of patients that we care for. Attracting the best and brightest to the field of ID is a challenge that all our societies face especially in this era of dynamic healthcare changes and by working together we can develop more innovative ways of sparking the interest of medical trainees in the field of infectious diseases. Inviting both adult and pediatric ID training fellows to serve on the various IDSA committees has been an excellent way to expose these individuals to the inner workings of how policy and practice guidelines are created. However, we need to find ways to get pediatric and internal medicine residents involved in various aspects of IDSA. As been shown by other organizations, it is these young trainees who provide invaluable insight into the issues that we face and are very creative in their approaches to resolving these issues. They also serve as a vehicle to attracting medical student interest in this area of medicine. It would be an honor to serve on the IDSA Board and if elected I would enthusiastically work to support IDSA's efforts to create clinical initiatives, practice guidelines, and strong public health policies for patients of all ages (particularly infants, children, pregnant women and the elderly) and for ID practitioners in all the different areas of our specialty, and work to increase ID fellow, resident and medical student involvement in the society.


     

    Director #2 - Robert Charles Read, MD, FIDSA

    Education: Sheffield University, United Kingdom, 1982; Junior Resident positions in Leeds and Bristol, 1983-1986; Medical Research Council Registrar, Northwick Park Hospital and Clinical Research Centre, London, 1986-1988; Clinical Fellow, National Heart and Lung Institute, Imperial College, 1988-1991; Senior Registrar in Medicine, Royal Brompton Hospital, London, 1991; Infectious Disease Senior Fellow, Nottingham and Sheffield Hospitals, United Kingdom, 1992-1994; Visiting Postdoctoral Fellow, University of California San Francisco,  1994-1995.

    Current Appointment: Chair, Department of Clinical & Experimental Sciences (Department of Medicine) University of Southampton, UK; Professor, of Infectious Diseases and Attending Physician in Infectious Diseases to Southampton General Hospital. Director, NIHR Southampton Biomedical Research Center.  Previously Professor, Infectious Diseases, University of Sheffield and Royal Hallamshire Hospital, UK, 1995-2012.

    IDSA Participation:  2016 Max Finland Lecturer, IDWeek New Orleans;  IDSA Chair, Program Committee, IDWeek 2013; Member, Annual Meeting Program Committee 2009-2011, and ex officio 2014-2015; Member, IDSA Education Committee, 2013, Council Member responsible for IDSA liaison , European Society for Clinical Microbiology and Infectious Diseases (ESCMID), 2005-2012; FIDSA, 2008.

    Research Interests: Pathogenesis and Prevention of disease due to meningococci, pneumococci and influenza virus.

    Other:  Editor in Chief, Journal of Infection, 2005 – current; Editor in Chief, Current Opinion in Infectious Diseases, 2011-current; Member, Infectious Diseases Specialist Advisory Group, European Medicines Agency, 2010-2015; Member, EU 7th Framework Programme Evaluation Committee, 2010 – 2014; Elected member of Executive Committee and Scientific Affairs Officer, ESCMID, 2005 – 2012; Co-founder ESCMID Observership Program, 2008; Member, Writing Committee, ESCMID European Guidelines for treatment of bacterial meningitis, 2015, and European Respiratory Society Guidelines for the Management of Lower Respiratory Tract Infections, 2008; Chair, United Kingdom Specialty Group in Infectious Diseases and Clinical Microbiology, NIHR Clinical Research Network Co-ordinating Centre, 2008 –2015; Chair, UK National Institute for Health Research, Postdoctoral Fellowships Panel, 2011-2015; Member, Joint Committee on Vaccines and Immunisation (JCVI - UK sibling  of ACIP), 2013 – current; Chair, Pneumococcal Sub-Committee, JCVI, 2015-current; Member, Department of Health Pandemic Influenza Clinical Operations (PICO) Committee, 2009 – 2012; Member, Expert Advisory Group, Anti-Infectives, HIV and AIDS, Commission on Human Medicines, UK Department of Health, 2006 -2012; Fellow, Royal College of Physicians of London, 1997, Fellow, Royal College of Physicians of Glasgow, 2005. Fellow, ESCMID, 2017.

    Personal Statement: A member of the Society since 1991, the impetus for involvement in IDSAarose from early training opportunities that I was grateful to receive during my ID fellowship. Membership and then Chairmanship of the IDSA Annual Meeting Program Committee has introduced me to the culture and values of the society and also to many new friends and colleagues.What I will bring to the Board is an experienced international perspective that spans academic, clinical, regulatory, and public health protection domains. My particular focus will be to further encourage internationalisation of the Society especially the development of bilateral opportunities for US and foreign trainees to gain special experience.

     

    Director #2 - Susan J. Rehm, MD, FIDSA

     

    Education:  University of Nebraska, BA summa cum laude, 1975; University of Nebraska College of Medicine, MD summa cum laude, 1978; Medical Resident, Cleveland Clinic, 1978-1981; Infectious Disease Fellow, Cleveland Clinic, 1981-1983; Executive Coach Certificate, Case Western Reserve University Weatherhead School of Management, 2014-2015. 

    Current Appointments:  Vice Chair, Department of Infectious Disease and Executive Director, Physician Health, Cleveland Clinic; Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. 

    IDSA Participation:  Subcommittee for Development of Clinical Practice Guidelines for Outpatient Intravenous Antibiotic Therapy, 1996-1997 and 2001-2003; Practice Guidelines Committee, 2001-2004; Committee on Professional Development and Equity, 2001-2004; Reviewer for Clinical Infectious Diseases.

    Research Interests:  Endocarditis and infections of implanted cardiac devices; outpatient parenteral antibiotic therapy; new antibiotics; adult immunization; physician well-being.

    Other:  Anti-Infective Drugs Advisory Committee, U.S. Food and Drug Administration Center for Drug Evaluation and Research, 2008-2010; Fellowship Program Director, Infectious Disease, Cleveland Clinic, 1986-1994; Internal Medicine Residency Program Director, Cleveland Clinic, 1994-1997; Board of Governors, Cleveland Clinic, 1994-1999; Associate Chief of Staff, Cleveland Clinic, 1997-2005; AIDS Commission of Greater Cleveland, 1988-1991; Professional Advisory Board, Cleveland Clinic Home Care Services, 1985-2010 (Chair 1985-1998); Medical Advisory Board, Visiting Nurse Association of Cleveland, 1985-1991; Board of Trustees, AIDS Taskforce of Greater Cleveland, 2004-2011; Board of Directors, National Foundation for Infectious Diseases, 1988-2004; Medical Director, National Foundation for Infectious Diseases, 2004-2015; John P. Utz Leadership Award, National Foundation for Infectious Diseases, 2012; Master Clinician Award, Cleveland Clinic, 2016.

    Personal Statement:  In times of change, an organization's willingness to ask powerful questions speaks volumes about its values and priorities. IDSA has a superb track record of identifying significant issues (antimicrobial resistance, emerging infectious diseases, the value/role of infectious disease specialists, the pipeline for future ID clinicians, etc.); developing actionable recommendations; and communicating with professionals, policy-makers and the public.  The infectious disease community faces great challenges and abundant opportunities. We need to influence systems at all levels to reduce administrative burdens and allow us to achieve our full potential as a specialty and as individuals.

    It is more important than ever for IDSA leadership to have the courage to ask the tough questions that are relevant to its diverse constituency.  As we go forward, it will be vital to pay attention to the quality of life of our members. We need to recognize that professional interactions supported by IDSA build resilience and protect against burnout. Expanding programs that can help members thrive through coaching, mentoring, sponsorship and other relationships would strengthen our base and set the stage for a sustainable future.  I would be honored to have the opportunity to make lasting contributions to the IDSA through membership on its Board of Directors. Election to the Board would allow me to use my clinical, educational and advocacy experience in infectious diseases, my insights into organizational development and my passion for the specialty to build on the solid foundation established by IDSA.

     


     

    Director #3 - Victoria J. Fraser, MD. FIDSA

     

    Education:  William Woods College, BA summa cum laude, 1978; University of Missouri School of Medicine, MD, 1983; Intern and Resident in Internal Medicine, University of Colorado Health Sciences Center, 1983-1986; Chief Medical Resident, University of Colorado Health Sciences Center, 1986-1987; Fellow in Infectious Diseases, Barnes Hospital-Washington University, 1988-1991.

    Current Appointments:  Adolphus Busch Professor of Medicine and Chairman, Department of Medicine, Washington University School of Medicine; Physician-in-Chief, Barnes-Jewish Hospital; Attending Physician, Barnes-Jewish Hospital.

    IDSA Participation:  Antimicrobial Resistance Committee, 2012-2016.

    Research Interests:  Prevention and control of hospital-acquired infections, adverse events and medical errors; care of underserved patients, specifically patients with HIV/AIDS, sexually-transmitted infections, substance abuse and mental health problems; development and implementation of interventions to improve healthcare outcomes in multiple clinical settings; development and implementation of curriculum, IDPs, career development programs, mentor training, faculty development programs and evaluation and tracking of trainees.

    Other:   Co-Director, Division of Infectious Diseases, Washington University, 2004-2012; Society for Healthcare Epidemiology of America (SHEA), President 2007; Young Investigator Award, 2001; Mentor-Scholar Fund Award, 2009; SHEA Lectureship Award, 2011. Many committees; IDWeek Maxwell Finland Lecture Award, 2013; Association of Professionals in Infection Control (APIC)-SHEA Leadership Development Program Committee, 2016-present; Washington University, Academic Women's Network Mentoring Award, 2004; Distinguished Teaching Award, 2004 and 2005; Alumni Association Distinguished Faculty Award, Founders Day, 2014; Barnes-Jewish Hospital/Washington University Dr. Neville Grant Award for Clinical Excellence, 2002; University of Missouri School of Medicine Alumni Citation of Merit Award, 2016; National Institutes of Health (NIH) Microbiology and Infectious Diseases Study Section, 2012-2016; Department of Defense Peer-Reviewed Medical Research Program Study Section, 2015-present; multiple NIH and Agency for Healthcare Research and Quality (AHRQ) study sections and special emphasis review panels, 2006-present.

    Personal Statement:  The Infectious Diseases Society of America serves an incredibly important role advocating for infectious diseases physician trainees, public health, research, and policies that advance human health. These are incredibly challenging times. Now, more than ever, IDSA needs to advocate for research, scholarship, and rational policies that support the advancement of science, public health, discovery and education. IDSA has the unique opportunity to continue to expand diversity and leadership efforts for all of its members, and to work collaboratively with other organizations such as PIDS, HIVMA, SHEA and ASTMH to develop strategic plans and initiatives that will continue to ensure the advancement of infectious diseases practice and research in the future. I would like to serve on the IDSA Board because I am committed to mentoring and career development for the next generation of infectious diseases practitioners and scientists. I would like to use my experience and training to help promote infectious diseases physicians and the impact of their scholarship and roles in society. I hope to be able to serve as a conduit to broad areas of the membership to facilitate their engagement so we can better meet the needs of our membership so that we can be even more effective in the future.


     

    Director #3 - Dean L. Winslow, MD, FIDSA

     

    Education: Pennsylvania State University, BS Science with high distinction, 1974; Jefferson Medical College, MD, (Alpha Omega Alpha), 1976; Intern and Resident in Medicine, Medical Center of Delaware, 1976-1979; Fellow in Infectious Diseases, Ochsner Clinic, 1979-1981; United States Air Force (USAF) School of Aerospace Medicine, 1983; Air War College, 2007.

    Current Appointments: Professor and Vice Chair, Department of Medicine, Stanford University School of Medicine; Attending Physician, Stanford University Hospital and Veterans Administration Palo Alto Health Care System.

    IDSA Participation: Standards and Practice Guidelines Committee, 2011-2017 (Chair 2015-2017); member, Centers for Disease Control and Prevention (CDC) Healthcare Infection Control Practices Advisory Committee, 2017-present.

    Professional Interests: Bedside and didactic teaching, patient care, veterans' health, introducing undergraduates to careers in medicine.

    Other: Diplomate, American Board of Internal Medicine (Internal Medicine, 1979; Infectious Diseases 1982, 2013), David A. Rytand Clinical Teaching Award, 2014, 2015; Award for Humanitarian Service to the People of Iraq (Iraqi Army), 2008; Editorial Board, AIDS, 1992-2016; Associate Editor, Diagnostic Microbiology and Infectious Disease, 2013-present; National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID) AIDS Research Review Committee (study section member), 1990-2003; Founder (with Julie Parsonnet), The Eagle Fund Trust (providing aid to Syrian, Iraqi and Afghan refugees), 2015.

    Military Service: USAF/Air National Guard, 1980-2015; highest rank- Colonel; key assignments: Commander, 159th MDG, 1992-1995; State Air Surgeon, Delaware, 1995-2011; ANG Assistant to the Commander, 59th MDW, 2011-2014; Commander, 447th EMEDS, Baghdad, 2008. Decorations: Legion of Merit, Meritorious Service Medal (3), Air Medal (3), Aerial Achievement Medal (4), AF Combat Action Medal, Afghanistan Campaign Medal (2), Iraq Campaign Medal (4), Antarctica Service Medal, Humanitarian Service Medal (2), Small Arms Expert Marksmanship (2), NATO ISAF medal.

    Personal Statement: I'm very fortunate to have been an ID doctor in many roles: clinical (adult and pediatric), private practice, county hospital, biotech/pharma, bench and clinical research, and academia (including serving as fellowship program director). I see IDSA's priorities to include: support for research, reimbursement for clinical, stewardship, and infection control work, training programs, and our clinical practice guidelines. Support for and understanding of science in the US may be at an historic low point.  It is imperative for IDSA to be a strong voice (along with other scientific and professional organizations) to educate Americans (including our elected leaders) in the importance of science and research for our nation's future.  We need to partner with these organizations to advocate for funding for research sponsored by the NIH, CDC, National Science Foundation, Department of Defense, Department of Energy, Environmental Protection Agency, and others.  One of the most important things that our Society does which positively impacts the care of patients throughout the world is our development of guidelines for the treatment of infectious diseases. If elected to serve on the IDSA Board I would enjoy working with IDSA staff and the Standards and Practice Guidelines Committee to ensure we have the resources to develop and rapidly update these important guidelines including facilitation of online access and ability to electronically search these documents.

     

  • HIVMA Board of Directors 2017 Candidates

  • HIVMA Vice Chair - Judith Feinberg, MD, FIDSA

     

    Medical Education: Rush Medical College, 1975-1979; Rush-Presbyterian-St. Luke's Medical Center, Internal Medicine Internship and Residency, 1979-1982; University of California, Los Angeles, Infectious Diseases Fellowship, 1982-1984; American Board of Internal Medicine: Internal Medicine, 1982, Infectious Diseases, 1984.

    Primary Current Professional Activity:  Clinical research with a current focus on HIV prevention; expanding harm reduction programs; and mentorship of junior investigators

    Position: Professor of Medicine/Infectious Diseases & Professor of Behavioral Medicine and Psychiatry, West Virginia University; Chair, Pilot Projects Core, West Virginia Clinical and Translational Science Institute

    Other Relevant Activities/Appointments: Co-Principal Investigator (Co-PI), Johns Hopkins AIDS Clinical Trials Unit, 1990-1995; Co-PI, 1995-1999 and PI, University of Cincinnati AIDS Clinical Trials Unit, 1999-2010; Associate Director, University of Cincinnati Infectious Diseases Center, 1995-2000; Chair of the Coordinating Committee on Therapeutics, NIH Office of AIDS Research, 1995-1997; Chair, Board of Directors, American Academy of HIV Medicine, 2003-2005; Associate Chair of Medicine for Faculty Development, 2007-2015; Founder and Medical Director, Cincinnati Exchange Project, 2014-present

    Committees:  IDSA AIDS Committee 1993-1997; Department of Health and Human Services (DHHS) Opportunistic Infections Guidelines Committee; DHHS Perinatal Guidelines Committee, 2007 to present; Food and Drug Administration Antiviral Drugs Advisory Committee: standing member, 1995-2000, invited member on multiple reviews, 1991 to present, chair of review of Truvada for PrEP, May 2012;  AIDS Clinical Trials Group, member of multiple committees, including: Executive Committee; Vice-Chair and Chair, Opportunistic Infections Committee; Chair, Clinical Endpoints Working Group

    Personal Statement: I have been involved in HIV care, research and education since the beginning of the epidemic, and have been fortunate to contribute to the transformation of this once-lethal disease into a manageable, chronic condition.  I have also long been involved in various public health aspects of HIV/AIDS, including resource allocation and policy development, the FDA approval process, service on DHHS guidelines committees, and the development of harm reduction programs to prevent the spread of HIV and hepatitis due to the current opioid epidemic.  While research has brought highly potent, well-tolerated, simpler therapies to people living with HIV, access to knowledgeable care, adherence and successful virologic suppression still eludes many, especially young black MSM whose infection rate is higher than Sub-Saharan Africa. In the absence of an effective vaccine, limiting HIV spread through 'Treatment as Prevention' and PrEP are key strategies that must be optimized. Reaching young black MSM for PrEP and care for those already infected is critical. The future of the Ryan White Program -- instrumental in providing care for the uninsured -- is uncertain; the ACA has provided access to care only in Medicaid expansion states and now faces elimination. These are all challenges that HIVMA must face through legislative advocacy and moral leadership. 

    Through my involvement in the development of care, research and education programs, in advocacy and policy work, I believe I have the experience, commitment and compassion to serve the patient and provider communities as Vice Chair. It would be an honor and privilege to do so. 


     

    HIVMA Vice Chair - Rajesh Gandhi, MD, FIDSA

     

    Medical Education: Harvard Medical School, MD, 1986; Internship and residency, Internal Medicine, Brigham and Women's Hospital (BWH), 1990-1993; Chief medical resident, BWH, 1994-1995; Fellowship, Medical Oncology, Dana Farber Cancer Institute, 1995-1998; Fellowship, Infectious Diseases, Johns Hopkins Hospital, 1998-2000.

    Primary Current Professional Activity: Staff physician and Director, HIV Clinical Services and Education, Massachusetts General Hospital (MGH); Professor of Medicine, Harvard Medical School. 

    Other Relevant Activities/Appointments: Site leader, MGH Clinical Research Site, AIDS Clinical Trials Group (ACTG); Member, Scientific Steering Committee, ACTG; Chair, ACTG HIV Reservoirs and Viral Eradication Transformative Science Group. Director, Harvard University Center for AIDS Research (CFAR) Clinical Core. Scientific member, Panel on Antiretroviral Guidelines for Adults and Adolescents, Department of Health and Human Services. Member, International Antiviral Society USA (IAS-USA) guidelines panel on Antiretroviral Treatment of Adult HIV infection. Editor, Partners ID Images, an educational infectious diseases website. Director, HIV Online Provider Education (HOPE) program, an educational conference series for physicians caring for people with HIV in resource-limited settings.  Deputy Editor, Journal Watch Infectious Diseases.  Elected to Board of Directors of the HIV Medicine Association (HIVMA), 2014.

    Personal Statement:  I have cared for people with HIV for 35 years. The honor of providing transformative care never fails to inspire me; to this day, meeting a person with HIV animates me with the feeling that I might help change the life of the individual entrusting me with their care.

    During my career, I have combined care of people with HIV with research on HIV reservoirs and immune control. Sharing my passion for HIV care and research is also a focus of my work: I write commentaries for Journal Watch Infectious Diseases, edit the Partners ID Images web-site, coordinate the HIV Online Provider Education training program, and organize an HIV medicine course in South Africa.

    I believe my passion for HIV care, research and education will make me a highly-effective vice-chair of HIVMA.  Given the social context in which people with HIV live and caregivers practice - and recent threats to progress in providing clinical care - I believe we must be outspoken in our advocacy for programs that are integral to the care of the people living with HIV. I believe new HIVMA programs and advocacy must be grounded in the care of the individual and inspired by the perspective that research and public policy provides to that care. I will pursue a vision informed by my work in clinical care, research and education to develop innovative HIVMA programs-and will represent the views and aspirations of people with HIV and fellow caregivers in this most exciting of medical and humanistic endeavors.


     

    HIVMA Infectious Diseases Seat - Maria L. Alcaide, MD, FIDSA

     

    Medical Education: University Autonoma Madrid: MD, 1997); Doce de Octubre Hospital, Madrid: Family Medicine, 2001; University of Miami, Jackson Memorial Hospital: Clinical Immunology/HIV Fellowship, 2002; Internal Medicine, 2005; Infectious Diseases, 2007; Board Certified: Internal Medicine, 2005; 2015; Infectious Diseases, 2007.

    Primary Current Professional Activity: Associate Professor of Clinical Medicine University of Miami Miller School of Medicine, 2013; Attending physician/faculty: HIV clinics, University of Miami/Jackson Memorial Hospital; Infectious Diseases Consultation Services, University of Miami Hospital, Jackson Memorial Hospital, Sylvester Cancer Center; AIDS Education Training Centers; Director, Miami Center for AIDS Research Clinical Core and Mentoring Program, University of Miami Infectious Diseases Research Unit; Key faculty and mentor, University of Miami/Jackson Memorial Hospital Infectious Diseases Fellowship Program and MD/PhD program; Research:  Principal investigator and co-investigator of federally and industry funded HIV care and prevention studies (Vaginal practices in HIV positive women in Zambia, a biobehavioral intervention - K23HD074489, Identification of the duration of Zika persistence to guide reproductive health decisions - Florida State grant, Women Interagency HIV Study WIHS - U01AI103397, Expanding Targets for HIV prevention in women - CFAR developmental award, Implementing Comprehensive PMTCT and HIV Prevention for South African Couples - R01HD078187, Simple, low cost assay for detection of HIV-1 antiretroviral resistance in resource limited settings - R41AI124932).

    Other Relevant Activities/Appointments: Co-Chair Female Reproductive Tract Pathogenesis working group WIHS; HIVMA Fellowship selection committee; Author of 50 scientific publications/chapters; Reviewer of high impact scientific journals and abstract of scientific meetings (e.g. Journal of Infectious Diseases, JAIDS, Sexually Transmitted Infections, ID week, IAS).

    Personal Statement:

    I have been a clinician caring for people living with HIV for over 15 years, and an HIV researcher for over 10 years. I practice HIV medicine in Miami, the city with the highest number of new HIV infections in the US. My research is in alignment with my clinical work and focuses on the study of HIV in women, especially among those from ethnic minorities and living in resource-limited settings.  I received an NIH diversity supplement and a K23 award. I direct the University of Miami Infectious Diseases Research Unit and the CFAR clinical core with the goal of promoting research to improve the lives of those living with HIV or those at risk for HIV infection. In addition to my clinical and research activities, and in order to support the development of the next generation of HIV providers and researchers, I direct the Miami CFAR mentoring program, I mentor medical students and infectious diseases fellows, and I provide formal training to non-infectious disease HIV practitioners.

    My experience and leadership roles as an HIV clinician, researcher and educator, make me an optimal candidate to serve in the leadership of the HIVMA as an infectious diseases representative. If selected, during my term I will continue to promote education to respond to the HIV epidemic, and advocate for policies that support HIV providers and researchers in the US and in resource-limited settings.


     

    HIVMA Infectious Diseases Seat - Demetre C. Daskalakis, MD, MPH

     

    Medical Education: NYU School of Medicine, MD, 1999; Beth Israel Deaconess Medical Center, Medical Internship, Residency, and Chief Residency, 1999-2003; Brigham and Women's/Massachusetts General Hospital, Infectious Disease Fellowship, 2003-2005; Harvard School of Public Health, Masters of Public Health, 2012

    Primary Current Professional Activity: Deputy Commissioner, Division of Disease Control, New York City Department of Health and Mental Hygiene, direct public health laboratory and all infectious disease control programs for New York City, including HIV, tuberculosis, sexually transmitted infections, vaccine-preventable diseases, and general communicable diseases in one of the largest in the department, employing more than 1000 staff, managing more than $350 million, and operating 17 clinical facilities; Associate Professor of Medicine and Infectious Diseases, Icahn School of Medicine, continue to care for people living with or at risk of HIV.

    Other Relevant Activities/Appointments: NASTAD-Member, Board of Directors, New York State Guidelines Committee-STD, NY State Ending the Epidemic Task Force-Prevention Subcommittee, Food and Drug Administration-Antimicrobial Drug Advisory Committee Member

    Personal Statement: Ending the epidemic of HIV is my mission. As a young, gay man living in New York City in the early 1990s, I witnessed the dark days of the epidemic before antiretrovirals became available. It was during those days that I decided to dedicate my medical career to HIV. As a student, I shadowed on the AIDS ward and saw firsthand the ravages of a virus. It was not until later that I realized that the virus was the symptom rather than the disease.

    Stigma, phobias, poverty, and silence created a fertile environment where HIV can flourish.  As a resident in Medicine and a fellow in Infectious Disease, I honed my skills clinically and in the research lab, but ultimately, public health was my passion. Having worked in municipal HIV clinics and as director of the HIV clinics at Mount Sinai, I saw the modern reality of HIV care in an urban setting.  When I had the opportunity to lead the HIV program at the NYC Department of Health, I learned the power of population health and how it was possible to take care of a city as your patient. At the Health Department, I was central in changing the tone of HIV prevention, launching PrEP, and working to re- invent the Sexually Transmitted Disease Clinics into centers of Sexual Health and HIV excellence. Working with HRSA, CDC, and other partners has prepared me to offer a valuable perspective to HIVMA while promoting the attainable vision of ending AIDS.


     

    HIVMA Infectious Diseases Seat - Steven C. Johnson, MD, FIDSA

     

    Medical Education: Northwestern University Medical School, 1980-1984; Internal Medicine Residency, Fitzsimons Army Medical Center, 1984-1987; Infectious Diseases Fellowship, Walter Reed Army Medical Center, 1987-1990.

    Primary Current Professional Activity: Director, University of Colorado HIV/AIDS Clinical Program; Associate Division Head for Clinical Affairs and Professor of Medicine in the Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine.

    Other Relevant Activities/Appointments: Medical Director, Colorado AIDS Education and Training Center; Director, Ryan White Program at the University of Colorado Hospital and School of Medicine; On-Site Consultant, HIV Collaborative Clinics in Durango, Fort Collins, Grand Junction, and Pueblo, Colorado.

    Personal Statement: The care of persons living with HIV has been the focus of my professional career. My current role at the University of Colorado School of Medicine is to oversee a Ryan White-funded clinical program that cares for over 2,000 persons living with HIV infection. I also frequently lecture on HIV infection through the University of Colorado, the Colorado AIDS Education and Training Center, and the Mountain-West AIDS Education and Training Center. I have also provided trainings on antiretroviral therapy at multiple international sites in Africa and Asia. I am a co-investigator in the Colorado AIDS Clinical Trial Unit. I have participated in national efforts on the care of HIV infection including the HIVQUAL program, Ryan White national conferences, and as a member of the CDC-HRSA Advisory Committee on HIV, Viral Hepatitis, and STD Prevention and Treatment (2011-2014). I also have extensive experience with the Ryan White program through our state and local planning councils, priorities committees, and our own grants management. I believe this gives me an important background for national policy issues that impact on HIV care including health care reform, Medicaid expansion, preservation of Ryan White Program funding, enhancement of HIV research funding, and implementation of the National AIDS Strategy. 

     

    HIVMA Infectious Diseases Seat - Colleen F. Kelley MD, MPH

     

    Medical Education: University of Florida, BA, 1998; Emory University School of Medicine, MD, 2004; Emory University Rollins School of Public Health, MPH, 2004; Internship and Residency, University of California San Francisco 2004-2007; Infectious Diseases fellowship, Emory University, 2007-2010; Board Certified Internal Medicine, 2007; Board Certified Infectious Diseases, 2010.

    Primary Current Professional Activity:  Assistant Professor of Medicine, Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine; Assistant Professor, Department of Epidemiology, Rollins School of Public Health (secondary appointment).

    Other Relevant Activities/Appointments:  Associate Director, Clinical Core, Center for AIDS Research, Emory University (2015-present); Director, Case of the Week Clinical Conference, Division of Infectious Diseases, Emory University (2013-present); Affiliated Scientist, Yerkes National Primate Research Center, Emory University (2014-present), Author, 28 peer reviewed manuscripts and other publications.

    Personal Statement: A career in Infectious Diseases and HIV medicine is the ideal combination of engaging in fascinating science and the pursuit of social justice. I value the tremendous opportunity to work in HIV medicine in the Southeast, the center of the US HIV epidemic. As a clinician, I take great pride in providing superior primary care for my HIV positive patients and in training the next generation of HIV care providers at the Grady Infectious Disease Program where we care for over 6000 patients, almost all with advanced HIV disease. At the same time, I have a specific research focus on understanding HIV transmission and optimizing the utility and efficacy of biomedical HIV prevention interventions.  My multi-disciplinary background in clinical HIV medicine, HIV epidemiology and clinical outcomes research, and laboratory based HIV research allows me to engage in a wide array of projects focused on PrEP implementation in at-risk populations in Atlanta, understanding rectal HIV transmission with a translational immunology approach, and biomedical HIV prevention clinical trials.

    My experience in HIV clinical care, education, and biomedical HIV prevention will bring a unique perspective to the HIVMA Board. It is an exciting time in the HIV prevention field with existing (e.g. TDF/FTC PrEP) and new interventions (e.g. monoclonal antibodies and long-acting, injectable PrEP) on the horizon. The HIVMA will lead the way on the clinical use and implementation of these interventions and work towards ensuring that those in greatest need of these interventions have secure access, and I look forward to participating in these endeavors.


     

    HIVMA Infectious Diseases Seat - Anna K. Person, MD

     

    Medical Education: Macalester College, BA, 2000; George Washington University School of Medicine, MD, 2005; Internship and Residency, Duke University Medical Center, Durham, North Carolina, Department of Internal Medicine, 2005-2008; Fellowship, Infectious Diseases, Duke University Medical Center, Durham, North Carolina, 2008-2010; Board Certified in Internal Medicine, 2008, and Infectious Diseases, 2010

    Primary Current Professional Activity: Staff Physician, Department of Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee; Program Director, Infectious Diseases Fellowship Program, Vanderbilt University, Nashville, Tennessee. 

    Other Relevant Activities/Appointments: Member, Ryan White Medical Providers Steering Committee, 2013-present; Co-Chair, Ryan White Medical Providers Steering Committee, 2017; Clinical Director, Southeast AIDS Education and Training Center (SE AETC), 2015-present; HIVMA representative to IDSA ID Training Program Directors' Committee, 2016-present; Member, HIVMA Medical Student Grant Review Committee, 2015-present; Member, Caribbean, Central and South America network for HIV Epidemiology, 2011-present; Elective Director, HIV Testing and Counseling Elective for Medical Students, Vanderbilt University Medical Center, 2012-2013; Creator and Elective Director, HIV Medicine Elective for Medical Students, Vanderbilt University Medical Center, 2013-2015; Associate Elective Director, Infectious Diseases Advanced Clinical Elective, Vanderbilt University Medical Center,2015-present; CME Director, SE AETC, 2017-present.

    Personal Statement: My candidacy to be a Representative on the HIVMA Board is fueled by my interest in addressing the need to generate enthusiasm in young trainees for HIV care and ensuring future funding for HIV providers, clinics, and educational programs. My roles as a clinical HIV provider and Program Director of the Infectious Diseases Fellowship Program at Vanderbilt University provide me with a special vantage point to appreciate the significant challenges facing HIV medicine as a subspecialty. I am a proud member of the HIVMA (and serve as the HIVMA representative to the IDSA ID Training Program Directors' Committee) because of the strong advocacy work of the HIVMA, including addressing the significant challenge of encouraging new healthcare providers to choose HIV Medicine as a profession.  I have been fortunate to work with tireless colleagues at a large HIV clinic in the Southeast, in the hotbed of the HIV epidemic, where every day I am reminded of the importance of our work. My special interests and expertise within HIV care involve the care of transgender individuals living with HIV, and I have been honored to give lectures around the Southeast on the topic of the privilege of providing care for this special group. Most of my work recently has been on the topic of the HIV Workforce -- in a perfect synergy between my role as Fellowship Program Director and HIV provider, addressing the issue of the waning interest in the field of ID and HIV medicine is what energizes me daily.

     

    HIVMA Infectious Diseases Seat - Alice C. Thornton, MD, FIDSA

     

    Education:  Welch College, Nashville, TN, BS, 1985; Marshall University College of Medicine, Huntington, WV, MD, 1992; Internship and Residency, Wake Forest University, Department of Internal Medicine, Winston-Salem, NC, 1992-1995; Fellowship, Infectious Diseases, Indiana University Purdue University (IUPUI)  1995-1998;  Board Certified in Internal Medicine, 1995 , Infectious Diseases, 1999,2009, and HIV Medicine, 2004-2005, 2008-2009, 2010-2011; K30 Scholar-Career Training in Therapeutics and Translations Research, 2000-2003; BIRCWH Scholar, 2000-2003; (Building Interdisciplinary Research in Careers in Women's Health ); Scholar, Circle of Power Leadership Program for Women Faculty, 2006-2007; Scholar, UKHC Executive Healthcare Leadership Program, 2015-2016.

    Primary Current Professional Activity:  Chief, Division of Infectious Diseases, University of Kentucky College of Medicine; Medical Director, Bluegrass Care Clinic, University of Kentucky Health Care;  Professor of Medicine, University of Kentucky College of Medicine; Joint Appointment, Department of Epidemiology, University of Kentucky, College of Public Health.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

    Other Relevant Activities/Appointments:  Principal Investigator, Ryan White Early Intervention Services (HIV) Part C; RW Part B Kentucky HIV/AIDS Care Coordinator Program; Ryan White Part D Coordinated Services and Access to Research for Women, Infants, Children and Youth; KY AIDS Educational Training Center - Local Performance Site of Vanderbilt University SEAETC; Randomized Clinical Trial to Prevent Vascular Events in HIV - REPRIEVE (A5332) Massachusetts General Hospital.  Co-investigator,  Integrating Buprenorphine Treatment for Opioid Use Disorder in HIV Primary Care -AIDS United;  Role of Social Media and Mobile Apps in Sexual and Drug Co-Usage Networks of MSM - R03 NIDA; Combining Opioid Addiction Treatment Services with CARE for Infectious Endocarditis - CATS-CARE- UK College of Medicine and CCTS Multidisciplinary Value Program. Faculty/Educator, Assistant Fellowship Director Infectious Diseases , UK College of Medicine,1999-2000; Fellowship Director Infectious Diseases , UK College of Medicine (2011-2013) ; Program Director, Annual HIV/AIDS Intensive Clinical Update for Infectious Disease and HIV Specialists,2009-2017; Mentor, I am A Woman in STEM; Mentor, Kentucky Young Researchers Program; Member of the following organizations and committees :  Clinical Consultant, Diagnostic Compliance Site Visit -HRSA, 2002-2017;  Endocarditis Optimal Care Initiative- UKHealth Care; Substance Use Task Force - UKHealth Care; Infectious Diseases Society of America, 1995-2017, Fellow, 2013; HIV Medial Association, 2005-2017; Ryan White Medical Providers Coalition (RWMPC)Steering Committee , 2006-2017, and co-chair, 2013-2916;HIVMA Board Nominations Committee, May-June 2014.

    Personal Statement: Twenty-two years ago, I had a personal health crisis.  As a young physician, I was forced to become my own advocate for health care. That experience influenced the way I practice and ultimately resulted in me becoming the patient advocate I am today. My career has been dedicated to improving the understanding of HIV and optimal delivery of care systems for this challenging population. In 2001, I led the successful procurement of HRSA funding to provide outpatient Early Intervention Services to adults living with HIV/AIDS in central and eastern Kentucky. Our division successfully developed the Bluegrass Care Clinic (BCC); a multidisciplinary clinic for HIV related clinical research, medical provider's education, and delivery of excellent care. Through my involvement in the Ryan White Medical Provider's Coalition (RWMPC) I have learned more about health care policy and the importance of provider's involvement in it. As a Clinical Consultant for HRSA, I have observed HIV health care delivery across the nation.  It brings me joy to get to know my patients and to advocate for their care. I believe education of patients and medical trainees is very important for the future of HIV medical care. My personal and professional experience will assist me in being an effective infectious disease representative on the HIVMA Board.  In an ever changing health care environment, provider involvement and leadership is more important than ever.   I would love the opportunity to be involved in HIVMA leadership as we face challenges in delivery of HIV health care.

     

    HIVMA Internal Medicine/Family Medicine Seat - Marwan Haddad MD, MPH

     

    Medical Education:  Harvard University, Cambridge, Massachusetts, Bachelor of Arts, 1991; McGill University School of Medicine, Montreal, Quebec, Canada, Doctor of Medicine, 1997; University of Toronto School of Medicine, Toronto, Ontario, Canada, Residency in Family Medicine, 1999;  and Johns Hopkins School of Public Health, Baltimore, Maryland, Masters in Public Health, 2010. Board certified in Family Medicine, 2007; HIV medicine, 2007; Buprenorphine certified through DATA 2000 Waiver, 2006.

    Primary Current Professional Activity: Medical Director, Center for Key Populations (CKP), Community Health Center, Inc. (CHCI), Connecticut, New England's largest federally-qualified health center (FQHC) network with 14 sites and links to other FQHCs nationally, focusing on five key populations at the highest risk of acquiring or living with HIV: men who have sex with men, transgender women, people who inject drugs, people in prison, and sex workers; Senior Researcher, Weitzman Institute, CHCI, Connecticut; Assistant Clinical Professor of Family Medicine, Frank H. Netter School of Medicine, Quinnipiac University, Connecticut

    Other Relevant Activities/Appointments: Medical Director, Part C Early Intervention Services Grant, Ryan White HIV/AIDS Program, Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services, 2008 to present; Principal Investigator, Substance Abuse Service Expansion, HRSA, 2016 to present; Principal Investigator, Technology Enhanced Access to Coordinated Healthcare and Buprenorphine Maintenance Therapy (TEACH BMT) ECHO-Based Project, Substance Abuse and Mental Health Services Projects of Regional and National Significance, Substance Abuse and Mental Health Services Administration (SAMHSA), 2013 to 2016; Clinical Director, CHC, Inc., Transforming Primary Care for Lesbian, Gay, Bisexual, Transgender (LGBT) People, Centers for Disease Control and Prevention (CDC)/National Association of Community Health Centers (NACHC)/Weitzman Institute/Fenway Institute ECHO-Based Project, 2016 to 2017; Originator and Lead Faculty, CHC Project ECHO  HIV/HCV and CHC Project ECHO Buprenorphine, medical provider training, guidance, and mentorship on HIV, HCV, and Buprenorphine management through weekly didactic and case-based teaching, 2012 to present; ECHO Director, Integrating Treatment for Opioid Agonist Therapies, HIV and Tuberculosis into Primary Care in Ukraine Using ECHO-Based Strategies, National Institutes on Drug Abuse (R01 DA043125); Clinical Mentor, Capstone Projects, Frank H. Netter MD School of Medicine, Quinnipiac University, 2015 to present; Specialty Faculty, Nurse Practitioner Residency in Family Practice and Community Health, CHCI, 2007 to present; Research Preceptor, Health of Communities Course, Wesleyan University, Middletown, Connecticut, 2008 to present; Chair, HIV Quality Improvement Committee, CHCI, 2008 to present; Member, Committee of Medical Directors, CHCI, 2008 to present; Member, Medical Quality Improvement Committee, CHCI, 2006 to present; Member, Infection Control Committee, CHCI, 2012 to present; Member, National Viral Hepatitis Roundtable, 2012 to present; Lead Consultant, NACHC Hepatitis C Fact Sheet, Buprenorphine Fact Sheet, 2015; Member, Hepatitis C Work Group, American Association for the Study of Liver Diseases/American Gastroenterological Association Institute/The American Medical Association-convened Physician Consortium for Performance Improvement®, 2012-2013;  Recipient, Primary Care Leadership Award, for integrating HIV, HCV, and substance use management in primary care, Connecticut Center for Primary Care, 2011;  Chief Resident, Wellesley/St. Michael's Hospital, Family Medicine Program, University of Toronto School of Medicine; Chair, Section of Residents, College of Family Physicians of Canada.

    Personal Statement: For the past 20 years, integrating HIV medicine into primary care has been my passion. I am committed to quality care improvements by transforming healthcare delivery for PLWH and those at risk. I transitioned our large FQHC network from a specialty-based to a primary care model, including spearheading our patient-centered medical home efforts. To overcome health disparities, I established the Center for Key Populations (see above) to overcome health disparities by ensuring access to and delivery of evidence-based quality care. By recognizing the complexity of care needed for PLWH, I have integrated services that address HIV, HCV, addiction, LGBT health, homelessness, and mental health. I provide direct clinical care and advocate for better care and access to services at the local, state and national levels, including meetings with elected representatives in Congress through the HIVMA.

    To democratize evidence-based healthcare delivery for key populations within primary care, I established several Project ECHO activities, which have now expanded nationally for HIV, HCV, and Buprenorphine (and internationally for integrated care). ECHO provides continuous, distance-based learning and clinical support through video-conferencing with clinicians. I also teach local medical and APRN students and lecture at state and national conferences on HIV prevention and treatment, integrated care, and other related topics.

    I would be honored to serve on the HIVMA Board. My experience serving individuals at risk for and living with HIV in primary care combined with my enthusiasm to transform clinical care through innovation and research makes me well-suited to advance the HIVMA mission. 


     

    HIVMA Internal Medicine/Family Medicine Seat - Dushyantha Jayaweera, MD, MRCOG (UK), FACP, CIP

     

    Medical Education: University of Colombo, Sri Lanka, MD, 1976; Residency in OBGYN Sri Lanka 1977-1982; Critical Care Medicine North Middlesex Hospital London 1982-1983; Registrar in OBGYN Epsom District Hospital, 1983-1984: Registrar in Critical Care Medicine North Middlesex Hospital 1984-1986; Loyola and Hines VA Residency in Internal Medicine, 1986 -1989; Registrar in HIV and STD Nottingham Teaching Hospital UK, Senior Registrar in HIV and STD Coventry and Birmingham Teaching Hospital UK 1990-1992; Assistant Professor in Medicine University of Miami 1992-1997; Associate Professor in Medicine University of Miami 1998-2007; Professor of Clinical Medicine, University of Miami 2007 to date; IRB Vice Chair 2006-2008; IRB Chair 2009-20012; Associate Vice Provost of Human Subject Protection, 2012 -2015; Interim Executive Dean for Research and Research Education 2015-2016; Executive Dean for Research and Research Education, 2016 - to date

    Primary Current Professional Activity: Executive Dean for Research and Research Education, Professor of Clinical Medicine, University of Miami Miller School of Medicine, Staff Physician, Jackson Memorial Hospital, Miami, FL.

    Other Relevant Activities/Appointments: Co Investigator for Clinical and Translational Research Award (CTSA), Director Hub capacity development CTSA, as the former Associate Vice Provost for Human Subject Protection (spearheaded the successful accreditation of the human subject protection program of the University of Miami by the Association for the Accreditation of Human Research Protection Programs), Member of the Executive Committee and the Steering Committee One Florida Research Consortium, Member of the Center for AIDS Research (CFAR) leadership Team and Co Director with Dr. Margaret Fischl on HIV and Women, Visiting Professor to China (Beijing, Shanghai, Dalian, Nanjing, Hangzhou and Shenzhen), International Speaker in HIV/ HCV and research compliance to China, Colombia, Sri Lanka and India) Ryan White Grant physician, Director of the HCV HIV co infection clinic; Author, 65 peer-reviewed scientific articles in HIV and HCV related topics and presented over 88 abstracts at major conferences;  site principle investigator for over 60 clinical trials and investigator in 10 federally funded studies.

    Personal Statement: I have been involved in the care of HIV patients for 25 years, starting with my residency in Chicago. In the early years of the epidemic, I was involved in Clinical Trials in UK and later on with the ACTG. I helped to establish the first minority clinic for HIV in Miami in 2000. I was also in charge of a HIV fellowship program from 1998 - 2005 at the University of Miami. In 2001, I helped to initiate a HIV HCV co infection clinic, which later became a leading referral clinic for South Florida. I am one of the senior physicians in a Ryan White funded clinic where we coordinate care, including organ transplantation, for HIV patients and am a faculty member of the AETC for Florida. I am involved with the One Florida Research Consortium looking, am a senior member of the Miami CFAR, and have been working in HIV and women.

    My experience as an HIV clinician/ educator will help to bring the needs of the HIV community to the attention of the HIVMA Board. While research continues on to discover better HIV medications and a possible cure, it is critical to focus on what can be done quite well right now such as controlling the spread of the HIV and providing care to all. We need more primary care providers for HIV with adequate reimbursement to be sustainable. We must revive public awareness of HIV and battle to maintain programs that provide care for those who lack financial means.


     

    HIVMA Advanced Practice Practitioner Seat - Lynsay MacLaren, MPH, MPAS, PA-C

     

    Medical Education: University of Colorado Boulder, BA, 2004; University of Colorado Anschutz Medical Campus, MPH, 2008; University of Colorado Anschutz Medical Campus, MPAS, 2010; HIV Specialist (AAHIVS), 2016-Present

    Primary Current Professional Activity: Staff Clinician Whitman Walker Health, 2010- Present; Research Clinician, Whitman Walker Health, 2016-Present

    Other Relevant Activities/Appointments: Publication- Jason S. Haukoos, Michael S. Lyons, Christopher J. Lindsell, Emily Hopkins, Brooke Bender, Richard E. Rothman, Yu-Hsiang Hsieh, Lynsay A. MacLaren, Mark W. Thrun, Comilla Sasson, Richard L. Byyny: Derivation and Validation of the Denver Human Immunodeficiency Virus (HIV) Risk Score for Targeted HIV Screening, Am J Epidemiol 2012; Co-investigator, AIDS Clinical Trails Group (ACTG); Gilead, ViiV, and GlaxoSmithKline sponsored Studies; Multicenter AIDS Cohort Study (MACS)

    Personal Statement: I have always been interested in HIV. In Denver I helped develop an HIV Risk Score to identify and test high-risk emergency room patients as part of the final project for my MPH. This interest drew me to Whitman-Walker Health (WWH) after graduation from PA school in 2010.  WWH is a FQHC in Washington, DC whose mission is to serve the LGBT community with a special expertise in HIV care.  Over the past 7 years I have provided care to hundreds of people living with HIV. DC has one of the largest epidemics in the country so I have been exposed to a wide range of complications and stages of HIV/AIDS. In 2016 I expanded my role and start working in the research side of HIV. Over the past year I have been a part of numerous ACTG studies that aim to not only find a cure for HIV but also improve the lives of those living with the disease. I also have the privilege to be a part of MACS where I get work with patients who have been positive and in the study as long as I have been alive. Their stories have a great impact on me.

    As the Advanced Practice Practitioner on the Board of Directors for the HIVMA I would like to bring awareness to and highlight the role midlevel providers play in HIV care.  PAs and NPs can be found in all aspects of HIV care and research and provide invaluable experience and expertise.

     


     

| IDSA | Contact Us

© Copyright HIVMA 2017 HIV Medicine Association

Full Site Mobile Site